Dexamethasone NDC 69306-111

NDC codes

FDA NDC Directory

Product NDC (as listed)69306-111Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69306-0111Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69306-111-60	69306011160	60 TABLET in 1 BOTTLE, PLASTIC (69306-111-60)Marketed from Jun 25, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dexamethasone
Generic name (nonproprietary): dexamethasone
Active ingredients: Dexamethasone — 1 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Doc Rx
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 088306
Marketing start: Sep 15, 1983
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 69306-111_c479d9ec-ec8d-7228-e053-2a95a90a9644SPL ID c479d9ec-ec8d-7228-e053-2a95a90a9644SPL set ID f1c30431-554b-4161-9d8c-5795c689e0bdRxCUI 197579, 197581, 197582UNII 7S5I7G3JQLUPC 0369306111606, 0369306112306, 0369306114065
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469306011160 followed by a unit qualifier and the quantity

Package 69306-0111-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 11, 2021.

Indications (excerpt from the label)

INDICATIONS AND USAGE Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. Dermatologic Diseases Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (Stevens-Johnson syndrome). Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocortico…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 088306

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 088306
Product	Strength	Form · route	Labeler	Product NDC
Dexamethasone	Dexamethasone 1 mg/1	TabletOral	Bryant Ranch Prepack	63629-7850